Bionime Corporation Stock price
Equities
4737
TW0004737002
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
69.7 TWD | +1.90% | -0.29% | -6.82% |
Mar. 15 | Bionime Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Mar. 14 | Bionime Corporation Announces Dividend for the Year Ended December 31, 2023 | CI |
Sales 2024 * | 2.1B 65.58M | Sales 2025 * | - | Capitalization | 4.24B 133M |
---|---|---|---|---|---|
Net income 2024 * | 72M 2.25M | Net income 2025 * | - | EV / Sales 2024 * | 2.02 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
58.6
x | P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 53.81% |
1 day | +1.90% | ||
1 week | -0.29% | ||
Current month | -4.26% | ||
1 month | -4.65% | ||
3 months | -6.44% | ||
6 months | -5.56% | ||
Current year | -6.82% |
Managers | Title | Age | Since |
---|---|---|---|
Chun Mu Huang
CEO | Chief Executive Officer | - | 03-04-13 |
Hui Chen Chen
DFI | Director of Finance/CFO | - | 17-11-05 |
Zhi Long Yeh
CTO | Chief Tech/Sci/R&D Officer | - | 18-11-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chun Mu Huang
CEO | Chief Executive Officer | - | 03-04-13 |
Director/Board Member | - | 07-10-16 | |
Chung Kai Tai
BRD | Director/Board Member | - | 07-05-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 69.7 | +1.90% | 30,078 |
24-03-27 | 68.4 | -0.29% | 80,396 |
24-03-26 | 68.6 | -1.29% | 92,658 |
24-03-25 | 69.5 | -0.43% | 81,443 |
24-03-22 | 69.8 | -0.14% | 38,173 |
End-of-day quote Taiwan S.E., March 27, 2024
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.82% | 130M | |
-13.95% | 8.1B | |
-4.01% | 5.13B | |
-0.04% | 4.72B | |
-32.93% | 4.4B | |
+0.39% | 4.14B | |
+16.88% | 2.82B | |
+3.24% | 2.55B | |
+11.39% | 1.92B | |
+1.28% | 1.65B |